Generate Biomedicines, Inc. carries a market capitalization of 1.65B, placing it among publicly traded companies globally.
| Market Cap | 1.65B |
| Enterprise Value | N/A |
Generate Biomedicines, Inc.'s stock has gained approximately 2.05534% over the past 52 weeks. The 50-day moving average sits at 13.10, while the 200-day moving average is 12.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | 2.05534% |
| 50-Day Moving Average | 13.10 |
| 200-Day Moving Average | 12.89 |
| Average Volume (20 Days) | N/A |